OncUpdates

990 posts

OncUpdates

@OncUpdates

Latest oncology insights for medical professionals and patients | curating cancer news, trials, & advances in cancer care |Own Views| Not medical advice

Worldwide Katılım Kasım 2024

658 Takip Edilen681 Takipçiler

Sabitlenmiş Tweet

OncUpdates@OncUpdates·9h

⭐️ NEW 🎥⭐️ @sophia_kamran highlights 🔑 #GU26 abstracts with Dr.Reizine: 🔹 POSEIDON: Very low PSA (<0.5 ng/mL) patients may skip short-term ADT during salvage RT if favorable features 🔹 SunRISe-2: Bladder drug-device + IO ❌didn’t beat chemoradiation oncupdates.com/video-podcasts…

English

OncUpdates retweetledi

Oncology Brothers@OncBrothers·7h

In 1L cHL Stg III or IV, #Nivolumab + AVD is now ✅ @US_FDA approved based off @SWOG 1826 (vs. #Brentuximab + AVD): - mPFS not reached. PFS HR: 0.42 - ⬆️ neuropathy & discontinuation w/ Bv-AVD - Adopted in clinical practice since its presentation. Now SoC #lysm #HemeTwitter

English

2.7K

OncUpdates retweetledi

Oncology Brothers@OncBrothers·11h

These numbers don’t tell the full story! Great summary by @GIcancerDoc on key real questions in the comments: 1. Is ctDNA ready for all? 2. Can we skip surgery after IO? 3. How much IO is good enough? 4. Role of Chemo here? #OncTwitter #gism @OncUpdates @manjuggm

Oncology Brothers@OncBrothers

For dMMR colon cancer, clinical Stage II (cT3-4N0 by imaging) do you rely on Ipi-Nivo upfront (NICHE-2) or Adj treatment (if upstaged per ATOMIC)? #gism @MyriamChalabi @FASinicropeMD @BijoyTelivala @CathyEngMD @GIcancerDoc @manjuggm @dr_yakupergun @GIMedOnc @pashtoonkasi

English

1.4K

OncUpdates@OncUpdates·11h

🎉 MATCH DAY 2026 IS HERE! 🎉 ⭐️Huge congratulations to every medical student and graduate who will find out where they matched into residency today! #MatchDay2026 #TheMatch #ResidencyMatch #MedTwitter #MedStudentTwitter #Match2026 @Inside_TheMatch

English

202

OncUpdates@OncUpdates·12h

@BrendanGuercio Thank you @BrendanGuercio for all your insights and the excellent discussion!

English

OncUpdates retweetledi

Brendan Guercio@BrendanGuercio·1d

Great catching up with Miles Hsu at #GU26 to discuss the evolving HER2-targeted landscape. Exciting to see how agents like disitamab vedotin are poised to reshape treatment paradigms for our patients with #BladderCancer. #ASCOGU26

OncUpdates@OncUpdates

⭐️ #UrothelialCancer insights from #ASCOGU2026! @BrendanGuercio from @WilmotCancer discusses with Dr. Hsu #HER2 targeted therapies! ✅ T-DXd shines even in low HER2 ✅ DV + PD-1 inhibitor had comparable efficacy to EV+P #OncTwitter #FOAMed Watch 🎙️👇 oncupdates.com/video-podcasts…

English

649

OncUpdates@OncUpdates·12h

@UICancerCenter @MassGeneralMDs @ASCO @ASCOTECAG @HemOncFellows #OncTwitter #MedTwitter #FOAMEd #MedEd

QME

OncUpdates@OncUpdates·1d

@aadel_chaudhuri @drgandara @MayoRadOnc @AaronNewmanLab @StanfordCancer @NIH Congrats 🎉!

English

Aadel Chaudhuri, MD PhD@aadel_chaudhuri·1d

Humbled to share that our latest R01 from @MayoRadOnc, in close collaboration with @AaronNewmanLab @StanfordCancer, was scored at the 1st percentile by @NIH study section. Grateful to an outstanding team and collaborators who made this possible, and excited for the work ahead!

English

5.4K

OncUpdates retweetledi

Oncology Brothers@OncBrothers·1d

Here is the link to our full discussion with @DrScottTagawa on Prostate Cancer Treatment Algorithm! #OncTwitter #gusm #MedX @OncUpdates @WCMGUcancer @WeillCornell youtu.be/x0ibKyqIcnQ?si…

YouTube

English

6.8K

OncUpdates retweetledi

Oncology Brothers@OncBrothers·1d

Treatment Algorithm: #ProstateCancer discussion w/ @DrScottTagawa: ✅ Staging/Surveillance🩻modality ✅ ARPI vs. pluvicto vs. Chemo sequencing ✅ #GU26 updates Full 🗣️: ⭐️ OncBrothers & OncUpdates Website ⭐️ “Oncology Brothers” podcast #OncTwitter @OncUpdates #gusm

English

2.2K

OncUpdates@OncUpdates·1d

@DanaFarber @DanaFarberNews @brian_rini @tompowles1 @montypal @GUOncologyNow @KidneyCancer @OncNursingNews @oncologynursing @HemOncFellows

QAM

OncUpdates@OncUpdates·2d

⭐️ NEW Insights @ASCO #GU26 ⭐️LITESPARK-011: Belzutifan + lenvatinib 📈 beats cabo (PFS & ORR) ⭐️LITESPARK-022: Adj belzutifan + pembro ⬆️ DFS vs pembro in high-risk ccRCC. @DrChoueiri +@MikeSerzanMD discuss👇 + managing anemia🩸& hypoxia 🫁#OncTwitter oncupdates.com/video-podcasts…

English

OncUpdates@OncUpdates·1d

English

OncUpdates retweetledi

Karamvir Yadav@K_Yadavir·1d

Impact full article @stolaney1 Is pCR enough to override stage? This study suggests: 👉 YES (largely) But only if pCR is achieved. Otherwise: ⚠️ cT3–4, cN+, TNBC → worse outcomes 💡 Response-guided oncology is the future #PrecisionOncology #BreastCancer #MedTwitter @DFCI_BreastOnc @drsarahsam @ASCOPost @ASCO @DrBarbiOnc @CR_AACR @ValenzaCarmine @hoperugo @oncodaily @BCCare

English

1.1K

OncUpdates@OncUpdates·1d

@RimshaAfzal15 Congrats on the match!!

English

rimsha afzal@RimshaAfzal15·2d

On Monday morning, I received the best email of my life. I’m going to be a radiation oncologist ☢️ I have the honor of dedicating my life in service to patients undergoing cancer treatment, and I couldn’t be more grateful. 🤍 #match2026

English

488

7.8K

OncUpdates@OncUpdates·3d

⭐️@ASCO #GU26 Insights: Radiotherapy + Immunotherapy in Metastatic Clear Cell RCC! @MikeSerzanMD +@KalantriShreyas discuss #CYTOSHRINK! ❌ Did NOT improve PFS (primary endpoint) 🗣️ Biomarker Strategies (KIM-1) #OncTwitter #MedTwitter Full discussion👇 oncupdates.com/video-podcasts…

English

433

OncUpdates retweetledi

Dr. Nina Niu Sanford@NiuSanford·6d

Someone suggested I make a table summarizing the video. Here it is!

Dr. Nina Niu Sanford@NiuSanford

Have you ever wondered whether you need to hold systemic during RT due to concern for additive toxicity? See this 10 min video. Categorized by systemic type (cytoxic chemo, IO, TKI, BRAF, etc) & RT regimen (SBRT/conventional/palliative) Slides🧵& full video below. 1/8

English

157

368

49.2K

OncUpdates retweetledi

Oncology Brothers@OncBrothers·4d

Her2 testing is important given bucket ✅ of TDXd! But how we test and indications for TDXd vary across multiple disease sites. Full 🗣️ on Her2 testing in #BreastCancer: ⭐️On OncBrothers & @COR2EDMedEd website ⭐️ “Oncology Brothers” podcast #bcsm #OncTwitter @OncoAlert

English

OncUpdates@OncUpdates·3d

⭐️@OncBrothers breakdown this 🔑 study presented at @ASCO #GU26 #KEYNOTE-B15/EV-304 trial shows perioperative EV + pembro beats standard gem/cis in cisplatin-eligible MIBC! 🔹 24-mo EFS: 79.4% vs 66.2% 🔹 24-mo OS: 86.9% vs 81.3% 🔹 pCR: 55.8% vs 32.5% oncupdates.com/video-podcasts…

English

371

OncUpdates@OncUpdates·4d

🎙️ Ep. 2 is OUT‼️ Coordinating Systemic Therapy & Radical Cystectomy in #MIBC Panelists @reichard_chad @shilpaonc @siadaneshmand @MattGalsky join the @OncBrothers to 🗣️ multidisciplinary 🤝 coordination! #OncTwitter #Oncology #FOAMed #MedEd Full 🎥👇 oncupdates.com/video-podcasts…

English

1.3K

Keşfet

@US_FDA @SWOG @GIcancerDoc @manjuggm @Inside_TheMatch @BrendanGuercio @UICancerCenter @MassGeneralMDs